Epsilon Healthcare Limited (ASX:EPN)
0.0260
0.00 (0.00%)
Sep 30, 2026, 12:24 PM AEST
Epsilon Healthcare Revenue
Epsilon Healthcare had revenue of 7.59M AUD in the half year ending June 30, 2026, with 164.38% growth. This brings the company's revenue in the last twelve months to 13.58M, up 121.40% year-over-year. In the year 2025, Epsilon Healthcare had annual revenue of 9.39M with 67.74% growth.
Revenue (ttm)
13.58M
Revenue Growth
+121.40%
P/S Ratio
0.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.12M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.39M | 3.79M | 67.74% |
| Dec 31, 2024 | 5.60M | -1.05M | -15.81% |
| Dec 31, 2023 | 6.65M | 2.00M | 42.99% |
| Dec 31, 2022 | 4.65M | -846.35K | -15.39% |
| Dec 31, 2021 | 5.50M | -1.46M | -20.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 131.16M |
| Medical Developments International | 42.57M |
| ECS Botanics Holdings | 21.02M |
| IDT Australia | 20.38M |
| Elixinol Wellness | 15.90M |
| Peak Processing | 12.51M |
| Cann Group | 9.65M |
| Syntara | 6.93M |